An observational study in Catheterization, Peripheral and Infection, sponsored by Centre Hospitalier Universitaire de la Réunion. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-09-05.
Sponsored by Centre Hospitalier Universitaire de la Réunion · Observational
Septi-PICC study aims at assessing incidence of Peripherally Inserted Central Catheter (PICC)-related infections among patients managed in the University Hospital of La Reunion for PICC setting.
Septi-PICC is a prospective single-center study of infections related to PICCs setting at the South tertiary site of the University Hospital of La Reunion over one year with a follow-up of 6 months per patient.
All the complications such as thromboembolic, are collected during the follow-up.
It is planned a convenience sample of 400 patients over 18 years of age, except pregnant women.
6,687 studies on the registry are indexed under Infections; 807 are open to participants now.
This study's enrollment of 283 is above the median of 240 across 2,136 observational studies indexed under Infections.
Browse Infections studies →Centre Hospitalier Universitaire de la Réunion is the lead sponsor of 137 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients managed for a PICC setting in the tertiary care hospital
Exclusion Criteria:
Incidence of PICC-related infections
Time frame: 1 year with 6 months follow-up
Incidence of other complications following the PICC setting
Time frame: 6 months follow-up
Incidence of hospitalizations following the PICC setting
Time frame: 6 months follow-up
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de la Réunion